CTRI/2026/07/114183进行中（未招募）2/3 期
CLINICAL STUDY TO EVALUATE THE COMBINED EFFECT OF KARPASASTHYADI TAILA NASYA DASHANGA SHUNTI LEPA FOLLOWED BY PRASARINI KASHAYA IN COMPARISION WITH BALASAIREYAKA TAILA NASYA UPANAHA CHURNA LEPA FOLLOWED BY SHUNTI GUGGULU KASHAYA IN THE MANAGEMENT OF AVABAHUKA VIS-A-VIS ADHESIVE CAPSULITIS - NIL
DR AISHWARYA0 个研究点目标入组 40 人开始时间: 2026年7月25日最近更新:
试验速览
- 阶段
- 2/3 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •subjects fulfilling diagnostic criteria of avabahuka like shoola stabdata and bahupraspandahara
- •subjects between age group of 30 to 70 years irrespective of gender
排除标准
- •subjects with history of fracture and dislocation of shoulder joint will be excluded
- •subjects with uncontrolled diabetes and hypertension will be excluded
- •subjects sufferings from any other systemic disorders which interferes with the course of intervention will be excluded
- •subjects with skin diseases or allergic skin lesions over shoulder region
- •pregnant and lactating women
- •subjects who are unfit for nasya karma will be excluded
研究者
相似试验
进行中（未招募）
Unknown
Effectiveness of OjasNoor Renewal Serum for BrighteningCTRI/2026/07/114186VedaLume Private Limited, OjasNoor36
招募中
不适用
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease (J2A-MC-GZPR)Peripheral Arterial DiseasejRCT20312505701,205
招募中
1 期
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants with Advanced Solid Malignancies2024-511453-22-00Kumquat Biosciences Inc.112
招募中
2 期
A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus lomustine in patients with glioblastoma at first progressionGlioblastoma2022-501822-39-00Philogen S.p.A.113
招募中
不适用
An Exploratory Study of novel diuretic therapy for cirrhotic ascitesLiver cirrhosis with uncontrolled ascites complicated by Type 2 diabetes mellitusjRCT103125078610